← Browse by Condition
Medical Condition

atherosclerotic cardiovascular disease ascvd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06813911 Phase 3
Recruiting

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Enrollment
340 pts
Location
United States, China...
Sponsor
Novartis Pharmaceuticals
View Trial →